Loading...

You're on the old version of Simply Wall St. We will no longer be supporting this site, so we recommend you switch to our brand new platform.

Symrise

SWX:SY1
Snowflake Description

Adequate balance sheet with moderate growth potential.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
SY1
SWX
€12B
Market Cap
  1. Home
  2. CH
  3. Materials
Company description

Symrise AG develops, produces, and supplies fragrances, flavorings, cosmetic active ingredients, raw materials, and functional ingredients. The last earnings update was 21 days ago. More info.


Add to Portfolio Compare Print
SY1 Share Price and Events
7 Day Returns
0%
SWX:SY1
5.1%
CH Chemicals
10.7%
CH Market
1 Year Returns
6.2%
SWX:SY1
9.7%
CH Chemicals
-5.9%
CH Market
SY1 Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Symrise (SY1) 0% 0% 0% 6.2% 46% 53.8%
CH Chemicals 5.1% -4.1% -8.9% 9.7% 25.4% 42.3%
CH Market 10.7% -7.3% -13.9% -5.9% 2.6% -1.1%
1 Year Return vs Industry and Market
  • SY1 underperformed the Chemicals industry which returned 9.7% over the past year.
  • SY1 outperformed the Market in Switzerland which returned -5.9% over the past year.
Price Volatility
SY1
Industry
5yr Volatility vs Market

SY1 Value

 Is Symrise undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Symrise to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Symrise.

SWX:SY1 Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 22 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 4.6%
Perpetual Growth Rate 10-Year CH Government Bond Rate -0.6%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for SWX:SY1
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year CH Govt Bond Rate -0.6%
Equity Risk Premium S&P Global 5.4%
Chemicals Unlevered Beta Simply Wall St/ S&P Global 0.82
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.818 (1 + (1- 30%) (17.92%))
0.947
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.95
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= -0.55% + (0.947 * 5.44%)
4.6%

Discounted Cash Flow Calculation for SWX:SY1 using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Symrise is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

SWX:SY1 DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (EUR, Millions) Source Present Value
Discounted (@ 4.6%)
2020 355.23 Analyst x13 339.61
2021 414.24 Analyst x13 378.61
2022 447.67 Analyst x9 391.17
2023 498.50 Analyst x2 416.44
2024 531.00 Analyst x1 424.09
2025 551.67 Est @ 3.89% 421.22
2026 565.79 Est @ 2.56% 413.01
2027 574.99 Est @ 1.63% 401.27
2028 580.59 Est @ 0.97% 387.36
2029 583.59 Est @ 0.52% 372.24
Present value of next 10 years cash flows €3,945.00
SWX:SY1 DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= €583.59 × (1 + -0.55%) ÷ (4.6% – -0.55%)
€11,271.48
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= €11,271.48 ÷ (1 + 4.6%)10
€7,189.54
SWX:SY1 Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= €3,945.00 + €7,189.54
€11,134.54
Equity Value per Share
(EUR)
= Total value / Shares Outstanding
= €11,134.54 / 135.43
€82.22
SWX:SY1 Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in SWX:SY1 represents 1.11788x of XTRA:SY1
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
1.11788x
Value per Share
(Listing Adjusted, CHF)
= Value per Share (EUR) x Listing Adjustment Factor
= € 82.22 x 1.11788
CHF91.91
Value per share (CHF) From above. CHF91.91
Current discount Discount to share price of CHF95.02
= -1 x (CHF95.02 - CHF91.91) / CHF91.91
-3.4%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

  • The current share price of Symrise is above its future cash flow value.
Often investors are willing to pay a premium for a company that has a high dividend or the potential for future growth.
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Symrise's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Symrise's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
SWX:SY1 PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-12-31) in EUR €2.21
XTRA:SY1 Share Price ** XTRA (2020-03-31) in EUR €85
Switzerland Chemicals Industry PE Ratio Median Figure of 5 Publicly-Listed Chemicals Companies 27.4x
Switzerland Market PE Ratio Median Figure of 175 Publicly-Listed Companies 16.61x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Symrise.

SWX:SY1 PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= XTRA:SY1 Share Price ÷ EPS (both in EUR)

= 85 ÷ 2.21

38.41x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Symrise is overvalued based on earnings compared to the CH Chemicals industry average.
  • Symrise is overvalued based on earnings compared to the Switzerland market.
Price based on expected Growth
Does Symrise's expected growth come at a high price?
Raw Data
SWX:SY1 PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 38.41x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 22 Analysts
10.6%per year
Europe Chemicals Industry PEG Ratio Median Figure of 59 Publicly-Listed Chemicals Companies 1.13x
Switzerland Market PEG Ratio Median Figure of 125 Publicly-Listed Companies 1.69x

*Line of best fit is calculated by linear regression .

SWX:SY1 PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 38.41x ÷ 10.6%

3.61x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Symrise is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Symrise's assets?
Raw Data
SWX:SY1 PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-12-31) in EUR €17.77
XTRA:SY1 Share Price * XTRA (2020-03-31) in EUR €85
Switzerland Chemicals Industry PB Ratio Median Figure of 7 Publicly-Listed Chemicals Companies 3.53x
Switzerland Market PB Ratio Median Figure of 216 Publicly-Listed Companies 1.33x
SWX:SY1 PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= XTRA:SY1 Share Price ÷ Book Value per Share (both in EUR)

= 85 ÷ 17.77

4.78x

* Primary Listing of Symrise.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Symrise is overvalued based on assets compared to the CH Chemicals industry average.
X
Value checks
We assess Symrise's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check)
  5. Symrise has a total score of 0/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

SY1 Future Performance

 How is Symrise expected to perform in the next 1 to 3 years based on estimates from 22 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
10.6%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Symrise expected to grow at an attractive rate?
  • Symrise's earnings growth is expected to exceed the low risk savings rate of -0.6%.
Growth vs Market Checks
  • Symrise's earnings growth is expected to exceed the Switzerland market average.
  • Symrise's revenue growth is expected to exceed the Switzerland market average.
Annual Growth Rates Comparison
Raw Data
SWX:SY1 Future Growth Rates Data Sources
Data Point Source Value (per year)
SWX:SY1 Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 22 Analysts 10.6%
SWX:SY1 Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 22 Analysts 6.5%
Switzerland Chemicals Industry Earnings Growth Rate Market Cap Weighted Average 11.9%
Switzerland Chemicals Industry Revenue Growth Rate Market Cap Weighted Average 5.3%
Switzerland Market Earnings Growth Rate Market Cap Weighted Average 8.7%
Switzerland Market Revenue Growth Rate Market Cap Weighted Average 2.3%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
SWX:SY1 Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 22 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
SWX:SY1 Future Estimates Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2024-12-31 4,865 786 499 2
2023-12-31 4,489 717 470 3
2022-12-31 4,186 664 434 12
2021-12-31 3,934 637 398 20
2020-12-31 3,719 585 355 22
2020-03-31
SWX:SY1 Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2019-12-31 3,408 547 298
2019-09-30 3,339 489 289
2019-06-30 3,271 431 279
2019-03-31 3,212 437 277
2018-12-31 3,154 442 275
2018-09-30 3,105 407 273
2018-06-30 3,056 373 271
2018-03-31 3,026 384 271
2017-12-31 2,996 396 270
2017-09-30 2,967 406 265
2017-06-30 2,956 414 260
2017-03-31 2,929 378 257

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Symrise's earnings are expected to grow by 10.6% yearly, however this is not considered high growth (20% yearly).
  • Symrise's revenue is expected to grow by 6.5% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
SWX:SY1 Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (3 months ago) See Below
Future Estimates Average of up to 22 Analyst Estimates (S&P Global) See Below

All data from Symrise Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SWX:SY1 Future Estimates Data
Date (Data in EUR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2024-12-31 3.63 3.63 3.63 1.00
2023-12-31 3.44 3.54 3.34 2.00
2022-12-31 3.19 3.50 2.93 9.00
2021-12-31 2.94 3.21 2.63 18.00
2020-12-31 2.61 2.82 2.30 18.00
2020-03-31
SWX:SY1 Past Financials Data
Date (Data in EUR Millions) EPS *
2019-12-31 2.21
2019-09-30 2.16
2019-06-30 2.11
2019-03-31 2.12
2018-12-31 2.12
2018-09-30 2.11
2018-06-30 2.09
2018-03-31 2.09
2017-12-31 2.08
2017-09-30 2.04
2017-06-30 2.00
2017-03-31 1.98

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Symrise is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Symrise's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Switzerland market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Switzerland market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Symrise has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

SY1 Past Performance

  How has Symrise performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Symrise's growth in the last year to its industry (Chemicals).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Symrise's year on year earnings growth rate has been positive over the past 5 years.
  • Symrise's 1-year earnings growth exceeds its 5-year average (8.3% vs 6.8%)
  • Symrise's earnings growth has not exceeded the CH Chemicals industry average in the past year (8.3% vs 10.1%).
Earnings and Revenue History
Symrise's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Symrise Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SWX:SY1 Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-12-31 3,407.85 298.31 728.31 213.35
2019-09-30 3,339.38 288.68 709.71 209.99
2019-06-30 3,270.90 279.05 691.11 206.63
2019-03-31 3,212.46 277.19 677.64 203.53
2018-12-31 3,154.03 275.33 664.17 200.44
2018-09-30 3,105.26 273.05 655.54 198.36
2018-06-30 3,056.49 270.78 646.92 196.28
2018-03-31 3,026.39 270.52 644.40 196.36
2017-12-31 2,996.29 270.27 641.89 196.43
2017-09-30 2,966.70 264.76 643.16 197.39
2017-06-30 2,955.94 260.37 638.90 194.82
2017-03-31 2,929.01 257.02 636.35 192.38
2016-12-31 2,903.19 252.36 627.82 185.98
2016-09-30 2,817.00 241.14 630.83 180.37
2016-06-30 2,733.48 247.02 614.65 175.67
2016-03-31 2,665.50 245.03 590.08 172.58
2015-12-31 2,601.73 246.78 585.10 169.64
2015-09-30 2,567.13 223.51 575.04 164.09
2015-06-30 2,509.08 217.26 555.45 159.72
2015-03-31 2,318.50 201.12 512.29 148.37
2014-12-31 2,120.11 185.00 461.67 138.89
2014-09-30 1,959.20 193.16 416.47 133.12
2014-06-30 1,837.46 180.23 389.26 127.51
2014-03-31 1,842.46 178.21 385.89 126.84
2013-12-31 1,830.39 172.34 385.99 127.00
2013-09-30 1,816.55 167.77 385.71 125.00
2013-06-30 1,798.07 164.17 378.07 122.31

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Symrise has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Symrise used its assets less efficiently than the CH Chemicals industry average last year based on Return on Assets.
  • Symrise's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Symrise's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Symrise has a total score of 2/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

SY1 Health

 How is Symrise's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Symrise's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Symrise is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Symrise's long term commitments exceed its cash and other short term assets.
Balance sheet
This treemap shows a more detailed breakdown of Symrise's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.1x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Symrise Company Filings, last reported 3 months ago.

SWX:SY1 Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2019-12-31 2,464.43 1,966.16 457.82
2019-09-30 2,464.43 1,966.16 457.82
2019-06-30 2,324.09 2,360.08 1,292.94
2019-03-31 2,324.09 2,360.08 1,292.94
2018-12-31 1,944.41 1,659.36 287.43
2018-09-30 1,944.41 1,659.36 287.43
2018-06-30 1,795.45 1,762.96 258.50
2018-03-31 1,795.45 1,762.96 258.50
2017-12-31 1,769.34 1,627.74 253.52
2017-09-30 1,769.34 1,627.74 253.52
2017-06-30 1,721.42 1,971.77 545.46
2017-03-31 1,721.42 1,971.77 545.46
2016-12-31 1,731.47 1,749.88 330.80
2016-09-30 1,555.27 1,846.81 316.83
2016-06-30 1,517.60 1,813.88 239.70
2016-03-31 1,555.03 1,707.57 230.53
2015-12-31 1,588.24 1,409.26 281.78
2015-09-30 1,526.88 1,409.02 223.94
2015-06-30 1,507.12 1,479.48 193.54
2015-03-31 1,504.76 1,369.69 205.33
2014-12-31 1,432.17 1,364.98 201.13
2014-09-30 1,443.30 1,436.56 210.75
2014-06-30 1,345.77 523.26 491.67
2014-03-31 984.09 524.40 134.98
2013-12-31 951.06 547.74 136.03
2013-09-30 933.84 592.27 119.62
2013-06-30 903.43 660.79 109.46
  • Symrise's level of debt (79.8%) compared to net worth is high (greater than 40%).
  • The level of debt compared to net worth has been reduced over the past 5 years (95.3% vs 79.8% today).
  • Debt is well covered by operating cash flow (27.8%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 13.2x coverage).
X
Financial health checks
We assess Symrise's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Symrise has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

SY1 Dividends

 What is Symrise's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
1.12%
Current annual income from Symrise dividends. Estimated to be 1.38% next year.
If you bought CHF2,000 of Symrise shares you are expected to receive CHF22 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Symrise's pays a lower dividend yield than the bottom 25% of dividend payers in Switzerland (2.11%).
  • Symrise's dividend is below the markets top 25% of dividend payers in Switzerland (4.26%).
Upcoming dividend payment

Purchase Symrise before the 'Ex-dividend' to receive their next dividend payment.

Dividends are usually paid every 3 or 6 months, you can time your share purchase to take advantage of upcoming dividend payments.
Dividend payment calendar
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
SWX:SY1 Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 22 Analyst Estimates (S&P Global) See Below
Switzerland Chemicals Industry Average Dividend Yield Market Cap Weighted Average of 5 Stocks 2.2%
Switzerland Market Average Dividend Yield Market Cap Weighted Average of 159 Stocks 3.3%
Switzerland Minimum Threshold Dividend Yield 10th Percentile 1.3%
Switzerland Bottom 25% Dividend Yield 25th Percentile 2.1%
Switzerland Top 25% Dividend Yield 75th Percentile 4.3%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

SWX:SY1 Future Dividends Estimate Data
Date (Data in €) Dividend per Share (annual) Avg. No. Analysts
2024-12-31 1.60 1.00
2023-12-31 1.55 2.00
2022-12-31 1.29 12.00
2021-12-31 1.17 22.00
2020-12-31 1.06 21.00
2020-03-31
SWX:SY1 Past Annualized Dividends Data
Date (Data in €) Dividend per share (annual) Avg. Yield (%)
2020-03-10 0.950 1.174
2019-03-13 0.900 1.040
2018-03-14 0.880 1.213
2017-03-14 0.850 1.313
2017-02-06 0.800 1.381
2015-03-10 0.750 1.278
2014-03-10 0.700 1.640
2013-03-12 0.650 1.995
2012-08-09 0.620 2.298
2012-05-17 0.620 2.586
2011-03-09 0.600 2.973
2010-03-03 0.500 2.607

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Symrise is not paying a notable dividend for Switzerland, therefore no need to check if the payments are stable.
  • Symrise is not paying a notable dividend for Switzerland, therefore no need to check if the payments are increasing.
Current Payout to shareholders
What portion of Symrise's earnings are paid to the shareholders as a dividend.
  • No need to calculate the sustainability of Symrise's dividends as it is not paying a notable one for Switzerland.
Future Payout to shareholders
  • Dividends after 3 years are expected to be well covered by earnings (2.6x coverage).
X
Income/ dividend checks
We assess Symrise's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.3%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Symrise afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Symrise has a total score of 1/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

SY1 Management

 What is the CEO of Symrise's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Heinz-Jürgen Bertram
COMPENSATION €2,456,795
AGE 61
TENURE AS CEO 10.7 years
CEO Bio

Dr. Heinz-Jürgen Bertram, Ph.D., has been Chairman of the Executive Board, Chief Executive Officer and Labour Director at Symrise AG since July 2009 and its has been Member of Executive Board since November 2006. Dr. Bertram served as Member of the Advisory Board at NORD/LB Norddeutsche Landesbank Girozentrale. He served as Member of Nomination Committee at Probi AB (publ). He served as President of Flavor & Nutrition Worldwide at Symrise AG. He served as President, Flavour Division at Symrise AG from 2006 to 2009; Chief Technology Officer & Global Head of Operations of Symrise AG from 2004 to 2006; Chief Technology Officer & President, Aroma Chemicals Division at Symrise AG from 2003 to 2004; Corporate Vice President, Corporate Research at Symrise AG from 2003 to 2003; Corporate Vice President , R&D at Haarmann & Reimer from 2002 to 2002; Corporate Vice President, R&D Flavors, H&R Holzminden, Haarmann & Reimer from 1999 to 2001; Vice President, Technical Services, H&R Florasynth, Teterboro, NJ, USA from 1997 to 1999; Director, Technical Services H&R Corporation, Springfield, NJ, USA from 1996 to 1997; Laboratory Manager, Flavour & Fragrance Research, Corporate Research, Haarmann & Reimer from 1990 to 1995; Laboratory Manager, Agrochemical & Pharmaceutical Research, Central Research, Bayer AG from 1987 to 1990 and Scientific Assistant, Institute for Organic Chemistry, at Leibniz University Hannover from 1985 to 1987. He serves as a Member of the Regional Board at Nord/LB-Holzminden and Member of the Board of Deutsche Bank - Region Hannover. He served as a Director of Novozymes A/S since 2015 until June 8, 2017. He served as an Director of Rockwool International A/S from 2011 to April 6, 2016. Dr. Bertram holds a PhD in Chemistry from University of Hannover, Germany in 1985 and Diploma in Chemistry from University of Hannover in 1987.

CEO Compensation
  • Heinz-Jürgen's compensation has been consistent with company performance over the past year, both up more than 20%.
  • Heinz-Jürgen's remuneration is lower than average for companies of similar size in Switzerland.
Management Team Tenure

Average tenure and age of the Symrise management team in years:

4
Average Tenure
57
Average Age
  • The tenure for the Symrise management team is about average.
Management Team

Heinz-Jürgen Bertram

TITLE
CEO, Chairman of Executive Board & Labour Director
COMPENSATION
€2M
AGE
61
TENURE
10.7 yrs

Olaf Klinger

TITLE
CFO & Member of Executive Board
COMPENSATION
€2M
AGE
53
TENURE
4 yrs

Achim Daub

TITLE
Member of Executive Board and President of Scent & Care Worldwide
COMPENSATION
€2M
AGE
57
TENURE
13.3 yrs

Heinrich Schaper

TITLE
President of Flavor Division & Member of Executive Board
COMPENSATION
€2M
AGE
63
TENURE
3.4 yrs

Jean-Yves Parisot

TITLE
President of Nutrition & Member of Executive Board
COMPENSATION
€2M
AGE
55
TENURE
3.4 yrs

Jürgen Nienhaus

TITLE
Corporate Vice President of Operations

Tobias Erfurth

TITLE
Head of Investor Relation

Roberto Ascoli

TITLE
Senior Vice President of New Business Development - Scent & Care Division

Béatrice Favre-Bulle

TITLE
Senior Vice President of Scent & Care

Alain Bourdon

TITLE
Managing Director of Madagascar
Board of Directors Tenure

Average tenure of the Symrise board of directors in years:

3.8
Average Tenure
  • The tenure for the Symrise board of directors is about average.
Board of Directors

Winfried Steeger

TITLE
Independent Chairman of the Supervisory Board
COMPENSATION
€109K
TENURE
0.6 yrs

Harald Feist

TITLE
Employee Representative Vice Chairman of the Supervisory Board
COMPENSATION
€116K
TENURE
1.4 yrs

Bernd Hirsch

TITLE
Independent Member of the Supervisory Board
COMPENSATION
€115K
AGE
49
TENURE
1.8 yrs

Horst-Otto Gerberding

TITLE
Independent Member of Supervisory Board
COMPENSATION
€77K

Peter Winkelmann

TITLE
Independent Member of Supervisory Board
COMPENSATION
€80K
TENURE
5.8 yrs

Xuemin Wang

TITLE
Member of Scientific Advisory Board

Andrea Pfeifer

TITLE
Independent Member of Supervisory Board
COMPENSATION
€77K
AGE
62
TENURE
8.8 yrs

Ursula Buck

TITLE
Independent Member of Supervisory Board
COMPENSATION
€80K
TENURE
3.8 yrs

André Kirchhoff

TITLE
Employee Representative Member of Supervisory Board
COMPENSATION
€76K
TENURE
3.8 yrs

Ludwig Tumbrink

TITLE
Employee Representative Member of Supervisory Board
COMPENSATION
€77K
TENURE
3.8 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CHF) Value (CHF)
X
Management checks
We assess Symrise's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Symrise has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

SY1 News

Simply Wall St News

SY1 Company Info

Description

Symrise AG develops, produces, and supplies fragrances, flavorings, cosmetic active ingredients, raw materials, and functional ingredients. It operates through three segments: Scent & Care, Flavor, and Nutrition. The Scent & Care segment develops, produces, and sells fragrance ingredients and compositions, cosmetic ingredients, and mint flours, as well as specific application processes for such substances. This segment’s products are used by manufacturer of perfumes, personal care and cosmetic products, cleaning products, detergents, air fresheners, and oral care products. The Flavor segment provides flavors and functional ingredients used in the production of foods, beverages, and health products. The Nutrition segments offers tailored solutions for use in foods, beverages, pet foods, aquacultures, and cosmetics. The company operates in Europe, Africa, the Middle East, North America, the Asia Pacific, and Latin America. Symrise AG was founded in 1874 and is headquartered in Holzminden, Germany.

Details
Name: Symrise AG
SY1
Exchange: SWX
Founded: 1874
€12,188,655,336
135,426,610
Website: http://www.symrise.com
Address: Symrise AG
Mühlenfeldstrasse 1,
Holzminden,
Lower Saxony, 37603,
Germany
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
XTRA SY1 Common Stock XETRA Trading Platform DE EUR 11. Dec 2006
OTCPK SYIE.F Common Stock Pink Sheets LLC US USD 11. Dec 2006
DB SY1 Common Stock Deutsche Boerse AG DE EUR 11. Dec 2006
LSE 0G6T Common Stock London Stock Exchange GB EUR 11. Dec 2006
SWX SY1 Common Stock SIX Swiss Exchange CH CHF 11. Dec 2006
WBAG SY1 Common Stock Wiener Boerse AG AT EUR 11. Dec 2006
BMV SY1 N Common Stock Bolsa Mexicana de Valores MX MXN 11. Dec 2006
BATS-CHIXE SY1D Common Stock BATS 'Chi-X Europe' GB EUR 11. Dec 2006
OTCPK SYIE.Y UNSP ADR EACH REPR 0.25 ORD Pink Sheets LLC US USD 13. Oct 2008
Number of employees
Current staff
Staff numbers
10,264
Symrise employees.
Industry
Specialty Chemicals
Materials
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2020/03/31 23:18
End of day share price update: 2020/03/31 00:00
Last estimates confirmation: 2020/03/30
Last earnings filing: 2020/03/10
Last earnings reported: 2019/12/31
Last annual earnings reported: 2019/12/31


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.